| User's Publication |
|
12538
Kaneya Y, Takata H, Wada R, Kure S, Ishino K, Kudo M, Kondo R, Taniai N, Ohashi R, Yoshida H, Naito Z.
Inhibitor for protein disulfide-isomerase family A member 3 enhances the antiproliferative effect of inhibitor for mechanistic target of rapamycin in liver cancer: An in vitro study on combination treatment with everolimus and 16F16
Oncol Lett
2021
21(1):28
PubMed ID: 33240434
|
|
12545
Aiyama T, Orimo T, Yokoo H, Ohata T, Hatanaka KC, Hatanaka Y, Fukai M, Kamiyama T, Taketomi A.
Adenomatous polyposis coli-binding protein end-binding 1 promotes hepatocellular carcinoma growth and metastasis
PLoS One
2020
15(9):e0239462
PubMed ID: 32956413
|
|
12546
Akutsu N, Yamamoto H, Sasaki S, Taniguchi H, Arimura Y, Imai K, Shinomura Y.
Association of glypican-3 expression with growth signaling molecules in hepatocellular carcinoma
World J Gastroenterol
2020
16(28):3521-8
PubMed ID: 20653060
|
|
13423
Zhiyong Wu, Xiaoyu Kong, Zhihui Wang
Integrin α7 knockdown suppresses cell proliferation, migration, invasion and endothelium-mesenchymal transformation in hepatocellular carcinoma
2019/1/1
|
|
12313
Sato Y, Yamada T, Hiroyama T, Sudo K, Hasegawa N, Hyodo I, Nakamura Y.
A robust culture method for maintaining tumorigenic cancer stem cells in the hepatocellular carcinoma cell line Li-7
Cancer Sci
2019
110(5):1644-1652
PubMed ID: 30784169
|
|
4276
Fujisaka Y, Iwata T, Tamai K, Nakamura M, Mochizuki M, Shibuya R, Yamaguchi K, Shimosegawa T, Satoh K.
Long non-coding RNA HOTAIR up-regulates chemokine (C-C motif) ligand 2 and promotes proliferation of macrophages and myeloid-derived suppressor cells in hepatocellular carcinoma cell lines.
Oncol Lett
2018
PubMed ID: 29387231
|
|
5802
Eguchi T et al
Organoids with cancer stem cell-like properties secrete exosomes and HSP90 in a 3D nanoenvironment.
PLoS One
2018
13(2):e0191109.
PubMed ID: 29415026
|
|
10240
Ohata T, Yokoo H, Kamiyama T, Fukai M, Aiyama T, Hatanaka Y, Hatanaka K, Wakayama K, Orimo T, Kakisaka T, Kobayashi N, Matsuno Y, Taketomi A.
Fatty acid-binding protein 5 function in hepatocellular carcinoma through induction of epithelial-mesenchymal transition.
Cancer Med
2017
6:1049-1061
PubMed ID: 28374947
|
|
9574
Ferraris P, Chandra PK, Panigrahi R, Aboulnasr F, Chava S, Kurt R, Pawlotsky JM, Wilkens L, Osterlund P, Hartmann R, Balart LA, Wu T, Dash S.
Cellular Mechanism for Impaired Hepatitis C Virus Clearance by Interferon Associated with IFNL3 Gene Polymorphisms Relates to Intrahepatic Interferon-λ Expression.
Am. J. Pathol.
2016
186:938-51
PubMed ID: 26896692
|
|
9576
Sugai S, Yoshikawa T, Iwama T, Tsuchiya N, Ueda N, Fujinami N, Shimomura M, Zhang R, Kaneko S, Uemura Y, Nakatsura T.
Hepatocellular carcinoma cell sensitivity to Vγ9Vδ2 T lymphocyte-mediated killing is increased by zoledronate.
Int. J. Oncol.
2016
48:1794-804
PubMed ID: 26936487
|
|
12537
Fujita K, Iwama H, Sakamoto T, Okura R, Kobayashi K, Takano J, Katsura A, Tatsuta M, Maeda E, Mimura S, Nomura T, Tani J, Miyoshi H, Morishita A, Yoneyama H, Yamana Y, Himoto T, Okano K, Suzuki Y, Niki T, Hirashima M, Masaki T.
Galectin-9 suppresses the growth of hepatocellular carcinoma via apoptosis in vitro and in vivo
Int J Oncol
2015
46(6):2419-30
PubMed ID: 25823465
|
|
12541
Soejima Y, Inoue M, Takahashi Y, Uozaki H, Sawabe M, Fukusato T.
ntegrins αvβ6, α6β4 and α3β1 are down-regulated in cholangiolocellular carcinoma but not cholangiocarcinoma
Hepatol Res
2014
44(14):E320-34
PubMed ID: 24552196
|
|
12542
Suzuki R, Aruga A, Kobayashi H, Yamato M, Yamamoto M.
Development of a novel in vivo cancer model using cell sheet engineering
Anticancer Res
2014
34(9):4747-54.
PubMed ID: 25202053
|
|
12543
Kinoshita H, Okabe H, Beppu T, Chikamoto A, Hayashi H, Imai K, Mima K, Nakagawa S, Ishimoto T, Miyake K, Yokoyama N, Ishiko T, Baba H.
Cystine/glutamic acid transporter is a novel marker for predicting poor survival in patients with hepatocellular carcinoma
Oncol Rep
2013
29(2):685-9
PubMed ID: 23229496
|
|
12544
Kumagai A, Fukushima J, Takikawa H, Fukuda T, Fukusato T.
Enhanced expression of farnesoid X receptor in human hepatocellular carcinoma
Hepatol Res
2013
43(9):959-69
PubMed ID: 23369163
|
|
12539
Kawano Y, Nagata M, Kohno T, Ichimiya A, Iwakiri T, Okumura M, Arimori K.
Caffeine increases the antitumor effect of Cisplatin in human hepatocellular carcinoma cells
Biol Pharm Bull
2012
35(3):400-7
PubMed ID: 22382328
|
|
5863
Yoshii Y, Waki A, Yoshida K, Kakezuka A, Kobayashi M, Namiki H, Kuroda Y, Kiyono Y, Yoshii H, Furukawa T, Asai T, Okazawa H, Gelovani JG, Fujibayashi Y.
The use of nanoimprinted scaffolds as 3D culture models to facilitate spontaneous tumor cell migration and well-regulated spheroid formation.
Biomaterials
2011
32(26):6052-8
PubMed ID: 21640378
|
|
12540
Futami K, Ogasawara S, Goto H, Yano H, Furuichi Y.
RecQL1 DNA repair helicase: A potential tumor marker and therapeutic target against hepatocellular carcinoma
Int J Mol Med
2010
25(4):537-45
PubMed ID: 20198302
|
|
6410
Danjoh I, Sone H, Noda N, Iimura E, Nagayoshi M, Saijo K, Hiroyama T, Nakamura Y.
Is parainfluenza virus a threatening virus for human cancer cell lines?
Hum Cell
2009
22(3):81-4
PubMed ID: 19624309
|
|
12536
Takeshi Yamada, Masato Abei, Inaho Danjoh, Ryoko Shirota, Taro Yamashita, Ichinosuke Hyodo, Yukio Nakamura
Identification of a unique hepatocellular carcinoma line, Li-7, with CD13(+) cancer stem cells hierarchy and population change upon its differentiation during culture and effects of sorafenib
BMC Cancer
2015
15:260
PubMed ID: 25885470
|
Back
Top
CELL BANK Website
